This is the authors' abstract. We don't add key points for this paper.
Our prospective, multi-institutional study demonstrated low rates of neurologic death when SRS/SRT as opposed to WBRT is used in patients with SCLC and 1-10 brain metastases who are surveilled closely post-treatment, supporting the utility of stereotactic approaches in this population.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Aizer et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: